Role of aspirin in primary prevention of cardiovascular disease
The benefits of aspirin therapy for the secondary prevention of cardiovascular disease clearly outweigh the risks of bleeding, and low-dose aspirin is uniformly recommended in this setting. However, no clear consensus exists about whether, and if so in whom, aspirin therapy is appropriate for the pr...
Κύριοι συγγραφείς: | Patrono, C, Baigent, C |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Springer Nature
2019
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
ανά: Baigent, C, κ.ά.
Έκδοση: (2003) -
Low-dose aspirin for the prevention of atherothrombosis.
ανά: Patrono, C, κ.ά.
Έκδοση: (2005) -
Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
ανά: Patrono, C, κ.ά.
Έκδοση: (2005) -
Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
ανά: Patrono, C, κ.ά.
Έκδοση: (2010) -
Prevention. Aspirin in primary prevention--good news and bad news.
ανά: Hennekens, C, κ.ά.
Έκδοση: (2012)